These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 34009657)

  • 21. COVID-19 vaccinology landscape in Africa.
    Baptista S; Naidoo S; Suliman S; Nepolo E; Kanoi BN; Gitaka J; Blessing OM; Enany S
    Front Immunol; 2022; 13():955168. PubMed ID: 36544758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 vaccines and treatments nationalism: Challenges for low-income countries and the attainment of the SDGs.
    Nhamo G; Chikodzi D; Kunene HP; Mashula N
    Glob Public Health; 2021 Mar; 16(3):319-339. PubMed ID: 33317389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Covid-19 vaccine passports: access, equity, and ethics.
    Osama T; Razai MS; Majeed A
    BMJ; 2021 Apr; 373():n861. PubMed ID: 33795260
    [No Abstract]   [Full Text] [Related]  

  • 24. The experience of disproportionate supplies of COVID-19 vaccines to Africa: the need for Africa to decolonize its public health response.
    Adeoye AO; Okunola JL; Fakunle SO
    Pan Afr Med J; 2023; 44():54. PubMed ID: 37128613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 vaccine equity in Africa.
    Turyasingura N; James WG; Vermund SH
    Trans R Soc Trop Med Hyg; 2023 Jun; 117(6):470-472. PubMed ID: 36622662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low coverage of COVID-19 vaccines in Africa: current evidence and the way forward.
    Lawal L; Aminu Bello M; Murwira T; Avoka C; Yusuf Ma'aruf S; Harrison Omonhinmin I; Maluleke P; Tsagkaris C; Onyeaka H
    Hum Vaccin Immunother; 2022 Dec; 18(1):2034457. PubMed ID: 35240908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Will access to COVID-19 vaccine in Aotearoa be equitable for priority populations?
    Whitehead J; Scott N; Carr PA; Lawrenson R
    N Z Med J; 2021 May; 134(1535):25-35. PubMed ID: 34012138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ethical limits to placebo use and access to Covid-19 vaccines as a human right.
    Greco DB
    Indian J Med Ethics; 2021; VI(2):1-14. PubMed ID: 33908350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccines: New challenges, new paradigms, new opportunities: Report of the 22nd DCVMN Annual General Meeting.
    Kumar Suri R; Hayman B; Prasad SD; Makhoana M; Tippoo P
    Vaccine; 2022 Jun; 40(26):3495-3505. PubMed ID: 35577632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Access considerations for a COVID-19 vaccine for South Africa.
    Bangalee V; Suleman F
    S Afr Fam Pract (2004); 2020 Oct; 62(1):e1-e4. PubMed ID: 33179954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ensuring the global COVID-19 vaccine equity: Universal vaccine access strategy in the context of low and-middle-income countries.
    Parray AA; Yadav UN; Das A; Ali AM; Mollick S; Saha S; Mistry SK
    Glob Public Health; 2022 Apr; 17(4):614-621. PubMed ID: 35050840
    [No Abstract]   [Full Text] [Related]  

  • 32. Out of Africa: A Solidarity-Based Approach to Vaccine Allocation.
    Jecker N; Atuire C
    Hastings Cent Rep; 2021 May; 51(3):27-36. PubMed ID: 33939182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ensuring equitable access to COVID-19 vaccines.
    Bull World Health Organ; 2020 Dec; 98(12):826-827. PubMed ID: 33293741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis.
    So AD; Woo J
    BMJ; 2020 Dec; 371():m4750. PubMed ID: 33323376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guiding equitable prioritisation of COVID-19 vaccine distribution and strategic deployment in South Africa to enhance effectiveness and access to vulnerable communities and prevent waste.
    Ovens W; Tomescu S; Harrison E; Crampton T; De Nooy A; Jassat W; Banoo S; Pisa P; Sanne I
    S Afr Med J; 2022 Feb; 112(2):13501. PubMed ID: 35139989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What It Will Take to Equitably Distribute a COVID-19 Vaccine.
    Medina-Walpole A
    J Gerontol Nurs; 2021 Jan; 47(1):47-48. PubMed ID: 33377984
    [No Abstract]   [Full Text] [Related]  

  • 37. COVID vaccines to reach poorest countries in 2023 - despite recent pledges.
    Padma TV
    Nature; 2021 Jul; 595(7867):342-343. PubMed ID: 34226742
    [No Abstract]   [Full Text] [Related]  

  • 38. COVID-19 Vaccine Global Access Is an Urgency.
    Negahdaripour M
    Iran J Med Sci; 2021 Mar; 46(2):79-80. PubMed ID: 33753951
    [No Abstract]   [Full Text] [Related]  

  • 39. Access to COVID-19 vaccines and testing in Africa: the importance of COVAX - Nigeria as a case study.
    Grenfell RFQ; Oyeyemi OT
    Pathog Glob Health; 2023 Mar; 117(2):152-166. PubMed ID: 35770309
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.